Introduction
Hematopoietic stem cells (HSCs) reside in a specialized micro-environment in the bone marrow (BM) known as the HSC niche, where numerous intrinsic and extrinsic regulatory factors combine to determine HSC fate 1 . One of these factors is transforming growth factor-β (TGFβ), an evolutionarily conserved growth factor with a well-documented, potent inhibitory effect on hematopoietic stem and progenitor cell (HSPC) proliferation in vitro [2] [3] [4] , as well as a role in HSC self-renewal in vivo [5] [6] [7] .
TGFβ signaling is initiated by ligand binding to the constitutively active serine/threonine kinase TGFβ receptor type II and subsequent recruitment of the TGFβ type I receptor to the ligand/receptor complex 8 . This initiates a phosphorylation cascade in which the downstream receptor activated (R)-Smads 2 and 3 are activated, allowing binding to the common (co)-Smad 4 and translocation to the nucleus where gene targets are regulated [9] [10] [11] . Central molecules in the TGFβ response are involved in all branches of Smad signaling, including those initiated by BMP and Activin. These are the inhibitory Smads (e.g. Smad7), which inhibit the whole signaling pathway, as well as Smad4, which is essential for transmitting the signal into the nucleus 9 . Interestingly, it has been demonstrated that the TGFβ signaling pathway is activated in HSCs in vivo 7, 12 and this activation seems to be critical for HSC maintenance as deletion of TGFβ receptor type II (TGFβRII) or Smad4 affects HSC function in vivo resulting in decreased repopulation capacity and selfrenewal 6, 7 . While the mechanism mediating TGFβ signaling is well characterized, the downstream effector molecules in hematopoietic progenitors are poorly understood. The cell cycle inhibitor p57 has been reported to be transcriptionally activated by TGFβ and to play a critical role in TGFβ-induced cell cycle arrest of hematopoietic progenitor cells 13 and HSCs 14 . Additionally, HSCs have been reported to express high levels of p57, while hematopoietic progenitor cells do not 12, [15] [16] [17] .
Furthermore, p57-deficient HSCs show a severely decreased self-renewal capacity and a reduced proportion of quiescent cells 18 , suggesting that TGFβ has a role in keeping HSCs in a quiescent state through a mechanism involving the transcriptional activation of p57.
Here, we set out to elucidate the effector mechanisms involving p57 downstream of TGFβ signaling in primitive hematopoietic cells. However, even though p57 mRNA levels were robustly upregulated following treatment of hematopoietic progenitor cells with recombinant human TGF-β1 (from now on referred to as TGFβ), the response was delayed and dependent on de novo protein synthesis, indicating that p57 is not an immediate effector molecule in the TGFβ response. Instead, we have identified the transcription factor (TF) Gata2, previously described as an important regulator of HSC function with similar functions as TGFβ and p57, 19, 20 as a Smaddependent, direct target of TGFβ signaling in hematopoietic progenitor cells. Our results further reveal a transcriptional network involving Gata2, p57 and members of the TGFβ signaling pathway. This regulatory network is active in HSCs and downregulated upon differentiation. However, we can show that upon TGFβ treatment hematopoietic progenitors upregulate Gata2 and the network is restored.
Importantly, Gata2 levels are critical for TGFβ-induced growth arrest demonstrating the functional importance for the TGFβ/Smad/Gata2/p57 axis in the regulation of hematopoietic progenitor cell proliferation. Thus, this study represents the first detailed mechanistic insight to TGFβ-induced growth arrest in the context of hematopoietic progenitor cells. 5 
Methods

Mice
Wild type C57Bl/6 mice were used for bone marrow (BM) harvest. Cre expression under influence of the Mx1-promotor was induced with three intraperitoneal injections of polyinositolic polycytidylic acid (pIC) of 250 or 400 µg at 2-day intervals in adult conditional MxCre/Smad4 fl/fl knockout mice 6 as well as in MxCre/Gata2 fl/fl knockout mice 21 . Littermate mice lacking Cre-expression were used as controls. BM was harvested from MxCre/Smad4 fl/fl mice and MxCre/Gata2 fl/fl mice 7-10 days and 1-5 days, respectively, after the last pIC injection. All mice were maintained according to Swedish animal guidelines at the animal facility at BMC, Lund University. All experiments were approved by the Lund University Animal Ethical Committee.
Cell preparations and cell culture
Femur, tibiae and iliac crests from each mouse were crushed and BM was filtered through a 70 μm cell strainer (Becton Dickinson (BD) Falcon or Fisher Scientific), enriched for c-kit + cells using positive magnetic selection (Miltenyi Biotec) and stained with fluorochrome conjugated antibodies for fluorescence-activated cell sorting (FACS). Cells were kept in PBS (Gibco) containing 2 % FCS (Gibco or Thermo Scientific). Murine BM was cultured in StemSpan Serum-free expansion medium (SFEM; StemCell Technologies) supplemented with 100 IU/ml penicillin, 100 µg/ml streptomycin (P/S, Gibco), 50 ng/ml murine stem cell factor (mSCF; PeproTech) and 50 ng/ml human thrombopoietin (hTPO; PeproTech). Lhx2 cells were cultured in Iscove's modified Dulbecco's medium containing L-glutamine and 25 mM HEPES (IMDM; Thermo scientific), supplemented with P/S, 10 -4 M 2-Mercaptoethanol (Sigma-Aldrich), 5 % FCS, 100 ng/ml mSCF and 10 ng/ml human interleukin 6 (hIL-6;
(PeproTech). When serum-free medium was required, FCS was replaced by 0.5 % BSA (StemCell Technologies). Where described, 0.05-10 ng/ml recombinant human TGF-β1 (TGFβ; R&D systems or Biovision) was added to cultures. An untreated control sample incubated in parallel with the TGFβ-treated sample was harvested at each indicated time point. Where cycloheximide (10 μg/ml) was used it was added to the cultures 3h prior to the start-point of the experiment.
Prior to global gene expression analysis, Lhx2 cells were serum-starved over night before treatment with 10 ng/ml TGF-β1 for 2 h. Untreated cells were used as controls.
Chromatin immunoprecipitation -sequencing (ChIP-Seq)
ChIP-Seq was performed as previously described 22 . Briefly, 1 × 10 8 Lhx2 cells were treated with 10 ng/ml TGFβ for 2h and then cross-linked with 1 % formaldehyde (Merck) for 15 min at room temperature before sonication using a Bioruptor.
Sheared chromatin (150-500 bp fragments) was incubated with 10 μg anti-GATA-2 sc9008 (Santa Cruz Biotechnology) overnight and chromatin-antibody complexes precipitated with Protein-G agarose (Roche). Library preparation and sequencing was carried out as described 22 . Reads were aligned to the mm9 version of the mouse genome using bowtie (19261174), and peaks were detected using MACS (18798982) and selected on having a 15-fold increase over the IgG control with a -10*log10(pvalue)>90.
ChIP-PCR
For analysis of LSK and cKit + cells, the ChIP procedure 22 was modified as follows to accommodate the reduced cell number. Cells (300,000 -6 million) were cross-linked and sonicated with solution volumes reduced as appropriate. Antibodies were preadsorbed to Protein G agarose, by incubating 2 ug of antibody (anti-GATA2 sc9008, anti-HA or normal rabbit serum IgG) with Protein G agarose (20 µl of a 50:50 slurry) in 100 ul RIPA buffer for 2 hours, before addition of BSA to 10 µg/µl for a further 30- 
RNA isolation and microarray hybridization
Total cellular RNA was isolated using Trizol reagent (Invitrogen) according to manufacturer's protocol. RNA concentration and integrity were determined by spectrophotometer (NanoDrop 1000, Thermo Scientific) and Bioanalyzer (2100 Expert, Agilent Technologies), respectively. Agilent's recommended procedures (Version 5.7, March 2008) were followed for the preparation and labeling of cDNA and hybridization, washing, scanning, and feature extraction of Agilent 60-mer oligonucleotide microarrays for microarray-based one-color gene expression analysis. Three independent RNA harvests were separately analyzed.
Analysis of microarray data
Arrays were normalized using cyclic-loess, and differentially expressed genes were identified using LIMMA (16646809) FDR< 0.2. Expression profiles were clustered using Genesis (11836235), and ontology analysis was carried out using DAVID (http://david.abcc.ncifcrf.gov/).
FACS
The following antibodies were used, either unconjugated or fluorochromeconjugated: anti-B220, -CD3, -CD4, -CD5, -CD8, -Gr1, -Mac1, -Ter119, -Sca1, -cKit, - 
Colony-forming unit (CFU) assays
Whole BM cells or cells sorted on the basis of surface markers were plated in methylcellulose (Methocult 3231; Stem Cell Technologies), supplemented with 20 % IMDM, 1 % P/S, 50 ng/ml mSCF, 10 ng/ml mIL-3 and 10 ng/ml hIL-6, with or without TGFβ at indicated concentrations, in 6 well plates. Colonies were counted 10-15 days after plating.
Statistical methods
Statistics were determined using Mann Whitney test, Wilcoxon matched-pairs signed rank test or Student´s t-test and the following significance levels were used: *P<0.05; **P<0.01; ***P <0.001.
Data has been deposited in The Gene Expression Omnibus under accession numbers
GSE73641 and GSM1899949.
Results
p57 expression is indirectly upregulated by TGFβ in primitive hematopoietic cells
The cell cycle inhibitor p57 is important for TGFβ-induced cell cycle arrest of HSPCs and its expression has been shown to be induced by TGFβ in primitive hematopoietic cells 13, 14 . To investigate how TGFβ affects p57 regulation in primary HSPCs over time, we performed a time course qPCR experiment where freshly sorted murine LSKCD34cells (HSCs) or LSKCD34 + cells (hematopoietic progenitor cells) were treated with TGFβ and harvested at different time points ( Fig 1A) . In agreement with earlier studies 13, 14 , qPCR analysis of p57 expression revealed a strong upregulation at 5 h (2.8-fold, P=0.045) and 12 h (6.4-fold; P=0.018) following TGFβ treatment, in the hematopoietic progenitor population ( Fig 1B) . However, when protein translation was blocked by cycloheximide treatment, TGFβ-induced upregulation of p57 was effectively diminished (<1.3-fold; Fig 1C) . Together, this data confirms previous findings of p57 as a downstream target of TGFβ but implies that p57 activation is a secondary effect dependent on the expression/activation of an additional transcriptional regulator. In HSCs ( Fig 1D) p57 mRNA levels were higher than in progenitor cells (see Fig 1B) upon harvest, and unaltered by TGFβ-treatment ( Fig 1D) , possibly due to the previously reported HSC niche-induced TGFβ signaling activity in these cells 7 . In the presence of cycloheximide TGFβ had no effect on p57 expression in HSCs ( Fig 1E) .
Global gene expression profiling reveals Gata2 as a target of TGFβ signaling
To identify early gene targets of TGFβ signaling in hematopoietic progenitor cells we performed high throughput gene expression profiling of a primitive murine hematopoietic cell line overexpressing the oncogene Lhx2 (Lhx2 cells), previously demonstrated to have in vivo multilineage reconstitution potential 23 . Lhx2 cells have been shown to be highly similar to primary HSCs in the composition of TGFβ/Smad signaling molecules and in TGFβ response 23, 24 , making them a good cell source for gene expression studies of TGFβ signaling, when large cell material is required. The 441 most differentially up-versus downregulated genes following 2 h TGFβtreatment were clustered in pathways involved in HSPC regulation using the DAVID database. A subset of these genes are listed in Table S1 and presented in a heatmap ( Fig 2A) . The microarray data confirm a change in expression of several genes previously known as TGFβ targets in other cell types, e.g. Smad7 25 , Skil 26 , Id1 27-30 , Id2 28, 29 , Id3 28, 30 , Hes1 [31] [32] [33] and Cited2 [34] [35] [36] , verifying the relevance of the array. The gene expression profiling additionally revealed a list of TFs (Table S2 ) responding early to TGFβ in primitive hematopoietic cells. Interestingly, among the TFs previously associated with stem cell activity only two genes (Hes1 and Gata2) had been related to an effect on the cell cycle 20, 37, 38 . To validate the results from the microarray we stimulated Lhx2 cells with TGFβ and harvested cells at different time points (using the same setup as for fresh HSPCs in Fig 1A) for qPCR analysis of the two well-known TGFβ targets Smad7 and Id1, as well as the TF Gata2. At 1-2 h following TGFβ treatment an upregulation of Smad7 ( Fig 2B) , Id1 ( Fig 2C) and Gata2 ( Fig 2D) was observed. In the presence of the translation inhibitor cycloheximide Smad7 induction was partly blunted, but importantly, all three genes were still upregulated in response to TGFβ ( Fig 2B-D) , confirming that they are direct targets of TGFβ signaling. This has previously been reported for Smad7 25 and Id1 27 , while
Gata2 has not been implicated in this context.
Gata2 is a Smad-dependent direct target of TGFβ in primary hematopoietic progenitor cells
To investigate whether TGFβ signaling affects Gata2 expression in primary HSPCs we performed a second time-course qPCR experiment, using murine HSCs and progenitor cells in place of Lhx2 cells ( Fig 1A) . Intriguingly, in freshly isolated cells, Gata2 showed an expression profile comparable to p57, with higher mRNA levels in the HSCs than in the progenitor cell population (compare Figs 3A and 3B).
Additionally, progenitor cells robustly upregulated Gata2 within 1-2 h following TGFβ-treatment (2.2-fold, P<0.002; Fig 3A) . The fact that this early upregulation was detected also in the presence of cycloheximide, demonstrates that Gata2 is a direct target of TGFβ signaling in primitive hematopoietic cells ( Fig 3C) . Similar to p57, Gata2 expression was unchanged in HSCs at early time points and under cycloheximide conditions (Fig 3B and 3D) .
Canonical TGFβ signaling has been shown to control proliferation of HSPCs through Smad proteins 5, 6 . To investigate if Gata2 and p57 are regulated via Smad signaling we used Smad4 -/-LSK cells, deficient in all canonical TGFβ signal transduction and resistant to TGFβ-induced growth arrest 6 . Following 2 h and 5 h TGFβ-treatment, Gata2 expression was significantly increased in WT total LSK cells compared to untreated control (1.4-fold and 1.8-fold respectively; P=0.004; Fig 3E) , while cells deficient in Smad4 did not upregulate Gata2 (Fig 3E) . Similarly, expression analysis of p57 in WT LSK cells showed a significant increase in gene expression after 5 h of TGFβ-treatment (2.1-fold; P=0.004; Fig 3F) , whereas TGFβ-treated Smad4 -/-LSK cells exhibited unaltered p57 expression ( Fig 3F) . This confirms that TGFβ-induced changes in Gata2 and p57 expression in hematopoietic progenitors are conveyed through Smad signaling.
Gata2 binds upstream the Cdkn1c (p57) genomic region
To gain further knowledge about the relationship between TGFβ and Gata2 we carried out GATA2-ChIP sequencing (ChIP-Seq) on 2 h TGFβ-treated Lhx2 cells ( Fig   4A) . Interestingly, there was a significant overlap (P<<0.001) between the GATA2 targets identified by ChIP-Seq and the downstream signature of TGFβ signaling as determined by microarray, comprising 110 genes ( Fig 4B; genes are listed in Table   S3 ). Both Smad7 and Gata2 were in this overlap while p57 was absent, possibly due to the short incubation (2 h) with TGFβ. Visual inspection of the ChIP-Seq data did however identify weak binding of GATA2 to the p57 promoter (data not shown). We verified these observations using qPCR of Gata2-bound chromatin in both Lhx2 and primary cells. The known -77kb Gata2 enhancer 39, 40 as well as the Smad7 intronic region and the p57 promoter region identified from the ChIP-Seq were all enriched by GATA2 immunoprecipitation in Lhx2 cells (Fig 4C-D) . Binding to the p57 promoter was further confirmed in a second multipotent cell line ( Fig S1) -as well as in primary cells ( Fig 4E-F) where the minimal amount of material needed for reliable ChIP-PCR results limited us to the use of LSK cells. Together, this data implies that Gata2 binds to the regulatory region of p57 as well as a large number of additional TGFβ targets.
Smad4 binds the Gata2 genomic locus
Based on our findings that TGFβ has a direct effect on Gata2 through Smad4 (Fig 3B   and C) we investigated possible binding of Smad4 to the regulatory regions of Gata2 in hematopoietic progenitor cells by ChIP-PCR. To this end an HA-tagged Smad4expressing vector was transduced to progenitor-enriched, cKit + BM cells to obtain sufficient material for HA-ChIP analysis. Following treatment with TGFβ for 2 h ( Fig   4A) we observed direct binding of Smad4, to the -77kb upstream enhancer of the Gata2 gene 39, 40 (Fig 4G) , strengthening the observations from our gene expression analysis. We could also detect binding of Smad4 to a Smad7 intronic region (identified from our ChIP-Seq data) suggesting Smad7 as a direct target of TGFβ signaling in these cells ( Fig 4G) .
Gata2 is critical for normal TGFβ function
To investigate the relevance for the TGFβ/Smad/Gata2/p57 network in the HSC niche in vivo we analyzed HSPCs freshly isolated from MxCre-inducible Smad4 6 knockout mice, deficient in TGFβ signaling ( Fig 5A) . Efficient out-floxing of Smad4 in this model has been shown previously 6 . Highly purified WT HSCs (LSKCD34 -CD48 -CD150 + ) measured 4.7-fold (P<0.001) higher Gata2 mRNA levels as compared to the LSKCD34 + cells ( Fig 5B) , and this differential expression was maintained in the Smad4 -/mice. Similarly, p57 was expressed 25.0-fold (P<0.001) higher in LSK CD34 -CD48 -CD150 + cells compared to the less primitive LSK CD34 + progenitor cells (Fig 5C) , demonstrating a correlation between the primitiveness of the hematopoietic cells and the level of Gata2 and p57 expression. Surprisingly, although Smad4 deletion did not affect Gata2 expression, purified HSCs from Smad4 -/mice still exhibited a 1.9fold lower baseline expression level of p57 compared to WT controls (P= 0.04, Fig   5C) . These results imply that TGFβ signaling is dispensable for Gata2 expression in HSCs and that loss of TGFβ signaling leads to a reduction of p57 levels independent of Gata2 levels. Thus, to clarify the role of Gata2 in this pathway we performed similar experiments in BM of inducible Gata2 knockout mice 21 . To verify deletion of Gata2 in this MxCre-mediated conditional knockout mouse model, we analyzed Gata2 expression in freshly isolated Lin -cKit + cells ( Fig S2A) ; mice showing 41-99% reduction of Gata2 mRNA were included in further analysis, presented as Gata2 KOs.
We also confirmed reduction/loss of Gata2 protein in bulk BM ( Fig S2B) and
performed PCR analysis of single colonies from CFU assays ( Fig S2C) . In concordance with previously reported findings of a reduction of HSCs in Gata2 haploinsufficient mice 19 , Gata2 deletion resulted in a loss of the immunophenotypic LSK population ( Fig S2D) . However, in Lin -cKit + progenitors we observed a significant reduction of p57 and Smad7 mRNA in the Gata2 -/background compared to littermate controls.
Importantly, TGFβ-induced upregulation of p57 was lost in Gata2 -/progenitors ( Fig   5F) and Smad7 upregulation was significantly impaired (Fig 5G) . To address the functional relevance for Gata2 in TGFβ-induced proliferation arrest we cultured lineage-depleted bone marrow cells from Gata2 heterozygous mice for four days in vitro with or without TGFβ. We found that loss of a single Gata2 allele rendered cells significantly less sensitive to TGFβ-induced proliferation arrest ( Fig 5H) . In accordance with this, Lin -cKit + cells purified from our GATA2 KO mice were less sensitive than WT cells to TGFβ-inhibition of colony formation (Fig S2E) , despite incomplete outfloxing in the Gata2 KO cells (some colonies were heterozygote from pcr; not shown) and thereby probably a selection for remaining WT cells in the colony assay. It should be noted that, as might be expected, Gata2 deletion alone markedly reduced colony output (see Fig S2D) and survival (not shown) in bulk culture. In summary these results imply that maintenance of physiological p57 levels specifically in HSCs requires the presence of TGFβ signaling (via Smad4), while maintenance of Gata2 levels in HSCs seem to be Smad4-independent. However, in hematopoietic progenitor cells maintenance of p57 expression was found to be Gata2-dependent suggesting that both Gata2 and Smad4 are required for the maintenance of p57. In addition, in progenitor cells TGFβ stimulation lead to a Smadmediated induction of both Gata2 and p57 levels and Gata2 was demonstrated to be critical for TGFβ-induced upregulation of p57 and subsequent proliferation arrest.
Taken together our results reveal a regulatory circuit between TGFβ/Smad4, Smad7, Gata2 and p57 critical for TGFβ-induced proliferation arrest of hematopoietic progenitor cells (Fig 6) .
Discussion
The importance of the TGFβ pathway in HSC biology has been highlighted by observations of the Smad pathway being specifically activated in HSCs, as well as studies in genetic mouse models where deletion of TGFβRII or Smad4 results in increased proliferation and decreased self-renewal of HSCs 6, 7, 14 . Accordingly, recent work suggests that the physiological relevance for TGFβ in HSC biology is to keep HSCs quiescent and re-establish HSC homeostasis following hematopoietic stress 14, 41 . However, the molecular mechanism underlying TGFβ-induced proliferation arrest is largely unknown. Interestingly, TGFβ has been found to induce expression of the cell cycle inhibitor p57 in HSPCs 13, 14 and this activation is crucial for TGFβ-induced cell cycle arrest in vitro 13 It is known that BM levels of TGFβ spike during recovery from hematologic stress directing the HSCs to return to quiescence, but the role of TGFβ in homeostasis is still controversial 41 . TGFβ signaling is also described to be adaptive 42 opening the possibility that Gata2 could be regulated differently by TGFβ during homeostasis than for example upon more sudden changes in TGFβ ligand concentrations. This theory is supported by our findings that steady state levels of Gata2 was unaffected in Smad4 -/cells while rapidly upregulated as a response to TGFβ treatment in vitro.
Knocking out the Gata2 gene strikingly attenuated the phenotypic LSK compartment by loss of Sca1 expression and reduced c-Kit expression within the Lincompartment.
This could be due to a converted HSC signature or more likely to the loss of the Gata2-deficient HSCs in line with observations in haploinsufficient Gata2 mice 19 and with Gata2-deficient human BM showing a complete absence of the primitive CD38cells within the CD34 + progenitor compartment [43] [44] [45] . Even though we were limited to study progenitor-enriched Gata2-deficient cells we found these cells to exhibit a strong reduction of colony-forming ability and to be desensitized to TGFβ-induced growth arrest. Additionally, loss of one Gata2 allele was adequate to make the progenitor-enriched cells less sensitive to TGFβ-induced proliferation arrest. Thus, in hematopoietic progenitor cells, Gata2 is upregulated upon activation of TGFβ signaling and required for proliferation arrest through a mechanism that includes transcriptional activation of the cell cycle inhibitor p57.
GATA2 has previously been shown to physically interact with SMAD4 in various cell lines and to be involved in negative regulation of TGFβ-induced erythroid differentiation 46 . This is yet another example of that TGFβ signaling activity can result in different responses depending on cell type and context. Furthermore, in a previous protein-protein interaction screen where mouse and human TF cDNAs were transfected into hamster epithelial ovary cells, human but not mouse GATA2 was reported to interact with SMAD4 as well as several of the TGFβ-regulated TFs identified in our microarray, i.e. PML and CEBPA 47 . Interestingly, in our ChIP experiments we could observe that GATA2 binds to the regulatory region of Pml and Smad4 binds to the regulatory region of Gata2, implicating several levels of TF interactions in primary murine hematopoietic cells and a mechanistic connection of this TF network to TGFβ signaling and subsequent regulation of proliferation.
The Smad7 genomic region was highly enriched by GATA2 in Lhx2 cells, indicating a direct regulation of the main negative feedback molecule of TGFβ signaling by Gata2.
We could show that Gata2 has an activating function on Smad7 since Gata2KO progenitor cells exhibited significantly dampened upregulation of Smad7 in response to TGFβ. The strong upregulation of Smad7 and modest increase of Gata2 levels in response to TGFβ in Lhx2 cells, along with the opposite observation upon translational block, make us speculate of the existence of a negative feedback mechanism between these genes that remains to be further investigated.
In our study we link together several molecules that have all been described to be of individual importance for HSC biology. Our approach is an important example of how studying interactions between regulatory molecules can provide a more comprehensive view of how these molecules are integrated and exert their downstream functions. Together, our data reveal a transcriptional network between TGFβ, Smad4, Smad7, Gata2, and p57, important for the regulation of hematopoietic progenitor cell proliferation. 
Figure legends
